electroCore to Participate at the 38th Annual Roth Conference

Company Overview - electroCore, Inc. is a bioelectronic medicine and wellness company focused on improving health and quality of life through innovative non-invasive bioelectronic technologies [4] - The company's leading prescription products include gammaCore, a non-invasive vagus nerve stimulation (nVNS) device for chronic pain syndromes, and Quell Fibromyalgia [4] - electroCore also offers handheld products like Trvuaga and TAC-STIM nVNS for general wellness and human performance [4] Event Participation - Management will participate in the 38th Annual Roth Conference from March 22-24, 2026, at the Ritz-Carlton in Laguna Niguel, California [1] - Joshua Lev, the Chief Financial Officer, will host one-on-one meetings during the conference [1] - Investors interested in scheduling meetings can contact their Roth representative or email investors@electrocore.com for more information [2] Conference Details - The Annual Roth Conference is one of the largest in the nation for small-cap companies, featuring company presentations, Q&A sessions, and management one-on-one meetings [3] - Approximately 500 private and public companies from various growth sectors will be represented at the conference [3] - Roth's Research Team identifies distinguished presenting companies across sectors such as consumer, energy, healthcare, industrial growth, metals & mining, sustainability, services, and technology [3]